Showing results (81-90 of 163) with videos related to
Sort By:
Pageof 17
RSC Advances|May 2, 2022
New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studiesMohammed M Alanazi, Hazem Elkady, Nawaf A Alsaif, et al.RSC Advances|April 24, 2025
Targeting VEGFR-2 in breast cancer: synthesis and in silico and in vitro characterization of quinoxaline-based inhibitorsIbrahim H Eissa, Alaa Elwan, Mustafa A Al-Qadhi, et al.Future Medicinal Chemistry|July 26, 2023
New thiouracil derivatives as histone deacetylase inhibitors and apoptosis inducers: design, synthesis and anticancer evaluationOmnia R Elbatrawy, Moshira A El Deeb, Mohamed Hagras, et al.Future Medicinal Chemistry|May 19, 2026
New chromene derivatives as promising VEGFR-2 inhibitors: combined experimental, DFT, and molecular dynamics approachesEslam B Elkaeed, Hazem Elkady, Walid E Elgammal, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|July 13, 2022
Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducersHeba S A Elzahabi, Eman S Nossier, Rania A Alasfoury, et al.Oxidative Medicine and Cellular Longevity|November 8, 2021
Inhibition of Vascular Smooth Muscle and Cancer Cell Proliferation by New VEGFR Inhibitors and Their Immunomodulator Effect: Design, Synthesis, and Biological EvaluationFeng Ran, Wendong Li, Yi Qin, et al.Evolutionary Bioinformatics Online|December 4, 2023
Computer-Assisted Drug Discovery of a Novel Theobromine Derivative as an EGFR Protein-Targeted Apoptosis InducerIbrahim H Eissa, Reda G Yousef, Eslam B Elkaeed, et al.Current Pharmaceutical Design|November 30, 2023
Design, Molecular Modeling, MD Simulations, Essential Dynamics, ADMET, DFT, Synthesis, Anti-proliferative, and Apoptotic Evaluations of a New Anti-VEGFR-2 Nicotinamide AnalogueIbrahim H Eissa, Eslam B Elkaeed, Hazem Elkady, et al.Molecules (Basel, Switzerland)|July 27, 2022
Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory EffectsEslam B Elkaeed, Reda G Yousef, Hazem Elkady, et al.Future Medicinal Chemistry|April 8, 2025
Design and synthesis of thiadiazoles as anticancer, apoptotic, and VEGFR-2 inhibitorsWalid E Elgammal, Hazem Elkady, Mohammed A Dahab, et al.Pageof 17